Latest News for: parp
Edit
The Role of PARP Inhibitors in Prostate Cancer Management
Jacksonville Free Press 18 Feb 2026
What Are PARP Inhibitors?. PARP inhibitors (often called PARPi) are cancer medicines you take as pills. PARP is a protein your cells use to fix small breaks in their DNA. PARP inhibitors block this repair process ... When Are PARP Inhibitors Used?.
Edit
Unexpected Cancer Drug Combo Shows Stronger Results Against Ovarian Tumors
Mega Doctor News 12 Feb 2026
A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better.
Edit
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination–proficient prostate cancer
PNAS 27 Jan 2026
SignificanceWhether patients with homologous recombination ...
Edit
Whole-genome sequencing may optimize PARP inhibitor use (Cornell University)
Public Technologies 14 Jan 2026
Tumors with this defect are vulnerable to PARP inhibitors, which further disrupt DNA repair, causing cancer cells to accumulate DNA damage and die ... if patients will benefit from PARP inhibitors.
Edit
Norfolk Daily News
20 Dec 2025
Tolmar Announces Expanded Indication for Rubraca® (rucaparib) First and Only PARP Inhibitor to Outperform Docetaxel ...
Norfolk Daily News
20 Dec 2025
FDA approval is based on the positive results of TRITON3, a ...
Edit
Tolmar Announces Expanded Indication for Rubraca® (rucaparib) First and Only PARP Inhibitor to Outperform Docetaxel in a Head-to-Head Phase 3 Trial
PR Newswire 19 Dec 2025- 1